|
FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug … FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular Events FDA warns of increased risks of asthma drug Xolair Xolair (omalizumab): Drug Safety Communication – Slightly Elevated Risk of … |
View full post on asthma – Google News